Friday 1 November 2013

Weekly Health news round up


It’s been a week where a raging storm hit the southern shores of the UK and transport came to a standstill, the ‘hacking scandal’ has finally come to court, and a proposed fizzy drink tax to tackle obesity…


Alzheimer's insight from DNA study


MS pill Tecfidera sales a triumph for Biogen


Actelion's PAH drug Opsumit recommended for EU approval


FDA suspends sale of Ariad’s cancer


29% of large trials unpublished after five years

 
Communicating diabetes to the online masses - how can pharma take advantage?
http://ow.ly/qp4cO

No comments: